Valneva SE (XBUL:AYJ)
лв 2.078 0 (0%) Market Cap: 580.89 Mil Enterprise Value: 669.08 Mil PE Ratio: 0 PB Ratio: 1.33 GF Score: 46/100

Valneva SE to Announce Agreement with GlaxoSmithKline PLC to End Strategic Alliance Agreement Call Transcript

Jun 21, 2019 / 07:30AM GMT
Operator

Good morning, ladies and gentlemen, and thank you for standing by. Welcome to today's Valneva Conference Call. (Operator Instructions) I must also advise you that this conference is being recorded today, Friday, the 21st of June 2019.

And I would now like to hand the conference over to your speaker today, Thomas Lingelbach. Please go ahead.

Thomas Lingelbach
Valneva SE - Chairman of the Management Board, President & CEO

Thanks a lot. Good morning, ladies and gentlemen. Yesterday evening, we announced major strategic decision and step for Valneva. We announced the mutual agreement with GSK to end our Strategic Alliance Agreement and by doing so regaining full control of our own R&D activities. We spoke to a couple of our key institutional investors yesterday evening already and got quite positive feedback on our decision, and as such, we are pleased to present to you today why we have decided to do so and what it means for Valneva and its strategic development going forward.

As you may recall, the Strategic Alliance Agreement was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot